Tag: organ transplantation

X-Therma Showcases Groundbreaking Organ Preservation Technology at Johns Hopkins’ “Hopkins on the Hill” Event

HERCULES, Calif., July 2, 2025 /PRNewswire/ -- X-Therma Inc., a pioneering biotechnology company revolutionizing organ preservation and regenerative medicine, proudly announces its participation in...

Hansa Biopharma presents positive outcomes of five-year follow-up study of imlifidase in kidney transplantation at ESOT Congress 2025 in London

LUND, Sweden, June 30, 2025 /PRNewswire/ -- Hansa Biopharma AB, "Hansa" (Nasdaq Stockholm: HNSA), announced today the presentation of its five year extended pooled...

Hansa Biopharma presents positive outcomes of five-year follow-up study of imlifidase in kidney transplantation at ESOT Congress 2025 in London

LUND, Sweden, June 30, 2025 /PRNewswire/ -- Hansa Biopharma AB, "Hansa" (Nasdaq Stockholm: HNSA), announced today the presentation of its five year extended pooled...

Antifreeze Protein Market to Reach $85.8 Million by 2032, Surging at a CAGR of 33.4% from 2025, Says Meticulous Research®

Market Growth Driven by Rising Frozen Food Demand, Medical Industry Applications, Urbanization Trends, and Advanced Cryopreservation Technologies REDDING, Calif., June 25, 2025 /PRNewswire/ -- According...

- A word from our sponsors -

Newsletter Signup

Name(Required)

First Last

Email(Required)

Enter Email Confirm Email

CAPTCHA

Privacy(Required)

I agree with the storage and handling of my data by this website. - Privacy Policy *

This field is for validation purposes and should be left unchanged.

HomeTagsOrgan transplantation

Invitation to Vitrolife Group’s presentation of the Q2 2025 interim report

SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Compass Diversified

RedCloud Announces Pricing of $13.5 Million Private Placement of Securities

Tag: organ transplantation

X-Therma Showcases Groundbreaking Organ Preservation Technology at Johns Hopkins’ “Hopkins on the Hill” Event

Hansa Biopharma presents positive outcomes of five-year follow-up study of imlifidase in kidney transplantation at ESOT Congress 2025 in London

Hansa Biopharma presents positive outcomes of five-year follow-up study of imlifidase in kidney transplantation at ESOT Congress 2025 in London

Antifreeze Protein Market to Reach $85.8 Million by 2032, Surging at a CAGR of 33.4% from 2025, Says Meticulous Research®

Newsletter Signup

Explore

Press Releases

News & Opinion

Living

Others

Follow us